PDF] Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis by Ri-Nan, Zheng · 3143460218 · OA.mg
PDF] Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. | Semantic Scholar
Figure 1 from The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel | Semantic Scholar
The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel | Drug Metabolism & Disposition
Pantoprazole On-Demand Effectively Treats Symptoms in Patients with GERD
Figure 1 from Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study | Semantic Scholar
Metabolic pathways of esomeprazole, omeprazole, lansoprazole,... | Download Scientific Diagram
In Vitro Evaluation of Phototoxic Properties of Proton Pump Inhibitors, H2-receptor Antagonists and Statins | HTML | Acta Dermato-Venereologica
Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis. - Abstract - Europe PMC